This approval, however, leaves Vorasidenib inaccessible to patients in the rest of the UK and Ireland. We support Brain Cancer Justice in their call to the NHS and NICE to introduce vorasidenib into the clinic UK-wide.
March is Brain Tumour Awareness Month🎗️🧠 Yesterday our team stood with Brain Cancer Justice at Parliament Square, to commemorate their petition reaching 109,000 signatures and being delivered to parliament for debate consideration
#BrainCancerAwarenessMonth#BrainCancerResearch
Some further positive news is yesterday’s approval of vorasidenib (Voranigo) by The Scottish Medicines Consortium for use in treating certain populations with IDH-mutated low grade gliomas (read more: https://t.co/9nlirwFzoh).
At CoSyne, we focus on speeding up the translation of treatments from the lab to the clinic, because we know time is the most valuable asset a patient has. We’re proud to be part of the UK’s life sciences community, working toward a day where "1 in 2" is a statistic of the past.
The conference provided many opportunities to seed new partnerships and establish pathways to translate our science into impact for rare disease patients in 2026. We also welcomed the chance to reconnect with the advisors, investors, and supporters who are integral to our mission
The CoSyne team got together at our Christmas party last week, for an afternoon filled with delicious food, thoughtful Secret Santa gifts, and finding out who had some hidden curling talents! 🎅🎁🥌
🎄✨ Merry Christmas & happy holidays from our team to yours!
Amazing work from the @CoSyneTx team led by @liisi_laaniste and @Louwai1 showing that through stratification therapies that are already approved can be put swiftly into action to improve the lives of those with brain tumors today. More to come!
https://t.co/oYiJETQTUJ
Our findings suggest that cytarabine could provide a targeted treatment option for a genetically defined group of patients with leptomeningeal dissemination of glioma, making an existing therapy newly actionable through biomarker guidance. [4/5]
This week, the CoSyne team are heading to the beautiful Honolulu to join the SNO meeting! 🌺🌴
Come and find us to hear about CoSyne’s latest exciting glioblastoma biomarker findings… more on that later in the week!
#SNO2025#glioblastoma#GBM#drugdiscovery#biomarkers
🧠 At CoSyne, we are proud to be supporting the International Brain Tumour Alliance (IBTA) during this year’s International Brain Tumour Awareness Week!
For more information, visit the IBTA's website here: https://t.co/HT4CKF0A3b
#IBTAWeek#braintumourawareness#glioblastoma
Winner winner chili dinner! 🌶️ 🏆 It turns out that brain cells aren’t the only thing we’re good at seeding…
Congrats to the experimental bio team in Cambridge who have taken out the JCBC chilli growing contest for most chilis on a single plant!